US Patent 11491130 Methods of treating amyotrophic lateral sclerosis
Patent 11491130 was granted and assigned to Retrotope Inc. on November, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Mikhail Sergeevich Shchepinov0
Peter Milner0
Edits on 23 Apr, 2023
Golden AI
Infobox
Edits on 30 Mar, 2023
Golden AI
Infobox
Edits on 9 Nov, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
Article (+237 characters)
US Patent 11491130 Methods of treating amyotrophic lateral sclerosis
Article
Disclosed are methods for inhibiting the progression of neurodegenerative disease. The methods include administering to a patient suffering from such a disease a composition comprising either deuterated linoleic acid or an ester thereof.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114911300
Date of Patent
November 8, 2022
0Patent Application Number
173919090
Date Filed
August 2, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11491130 Methods of treating amyotrophic lateral sclerosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.